Equity Overview
Price & Market Data
Price: $0.046
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $1,096,603
Volume: 0
Performance Metrics
1 Week: 37.11%
1 Month: -14.02%
3 Months: -24.09%
6 Months: -14.02%
1 Year: -60.28%
YTD: -9.80%
Details
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing diagnostics and psilocybin-based therapeutics for the treatment of neuroinflammatory disorders, including autism spectrum disorder and fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.